Dr. Robert W. Malone

Robert W. Malone, M.D., M.S.
Robert W. Malone, M.D., M.S.

Robert W. Malone is the discoverer of in-vitro and in-vivo RNA transfection and the inventor of mRNA vaccines, while he was at the Salk Institute in 1988. His research was continued at Vical in 1989, where the first in-vivo mammalian experiments were designed by him. The mRNA, constructs, reagents were developed at the Salk institute and Vical by Dr. Malone. The initial patent disclosures were written by Dr. Malone in 1988-1989. Dr. Malone was also an inventor of DNA vaccines in 1988 and 1989. This work results in over 10 patents and numerous publications, yielding about 7000 citations for this work. Dr. Malone was also an inventor of DNA vaccines in 1988 and 1989.

Dr. Malone has extensive research and development experience in the areas of pre-clinical discovery research, clinical trials, vaccines, gene therapy, bio-defense, and immunology. He has over twenty years of management and leadership experience in academia, pharmaceutical and biotechnology industries, as well as in governmental and non-governmental organizations.

Dr. Malone specializes in clinical research, medical affairs, regulatory affairs, project management, proposal management (large grants and contracts), vaccines and biodefense. This includes writing, developing, reviewing and managing vaccine, bio-threat and biologics clinical trials and clinical development strategies. He has been involved in developing, designing, and providing oversight of approximately forty phase 1 clinical trials and twenty phase 2 clinical trials, as well as five phase 3 clinical trials. He has served as medical director/medical monitor on approximately forty phase 1 clinical trials, and on twenty phase 2 clinical trials, including those run at vaccine-focused Clinical Research Organizations. His proposal development work has yielded clients billions of dollars.

Scientifically trained at UC Davis, UC San Diego, and at the Salk Institute Molecular Biology and Virology laboratories, Dr. Malone is an internationally recognized scientist (virology, immunology, molecular biology) and is known as one of the original inventors of mRNA vaccination and DNA Vaccination. His discoveries in mRNA non viral delivery systems are considered the key to the current COVID-19 vaccine strategies. Dr. Malone holds numerous fundamental domestic and foreign patents in the fields of gene delivery, delivery formulations, and vaccines.

He received his medical training at Northwestern University (MD) and Harvard University (Clinical Research Post Graduate) medical school, and in Pathology at UC Davis.

Dr. Malone has close to 100 peer-reviewed publications and published abstracts and has over 11,477 citations of his peer reviewed publications, as verified by Google Scholar.  His google scholar ranking is โ€œoutstandingโ€ for impact factors. He has been an invited speaker at over 50 conferences, has chaired numerous conferences and he has sat on or served as chairperson on numerous NIAID and DoD study sections.

Visit Robert W. Malone’s Website at RWMalonemd.com

Robert W. Malone, MD, MS Full CV PDF

Robert-W-Malone-CV-July-2021

The Thinking Conservative
The Thinking Conservativehttps://www.thethinkingconservative.com/
The goal of THE THINKING CONSERVATIVE is to help us educate ourselves on conservative topics of importance to our freedom and our pursuit of happiness. We do this by sharing conservative opinions on all kinds of subjects, from all types of people, and all kinds of media, in a way that will challenge our perceptions and help us to make educated choices.

The Looming Threat To Our Homeland

After success of โ€œOperation Midnight Hammer,โ€ where U.S. military bombed Iranian nuclear facilities, the threat to America has never been greater.

Groundhog Day came late this year to the Land of Smiles.

itโ€™s the same rigmarole, on whatever pretext, the army commandeers the Thai state with vague promises to restore democracy at some unspecified future date.

Resource number one

Russia has an unsustainable birthrate worsened by mortality rate of Russian males through war and alcoholism. One solution, steal young children from other countries.ย 

Expansionist CCP Runs Amok in Pacific After U.S. Relocates Naval Assets to Mid-East

Caveat established, Chinaโ€™s been going bananas on the high seas as the eyes of the world, and U.S. military assets, hone in on Iran.

The Anti-Trump Protests โ€“ Why Are They So Important?

The anti-Trump stance is not a political position, but a desperate gesture, a mental diagnosis of those who refuse to accept the reality of the World today.

Supreme Court Temporarily Allows Deportations to Third Countries

Supreme Court temporarily lifted lower court order blocking Trump admin from deporting illegals to so-called third countries they have no connection.

US Manufacturing Output, Hiring Rise to Multi-Month Highs

U.S. manufacturing activity climbed in June, fueled by strong domestic demand and tariff-driven stockpiling, according to report from S&P Global.

Largest US Power Grid Issues Emergency Energy Alerts

The alerts follow a report released last month that predicted that parts of the country would face difficulties meeting electricity demand during the summer.

No Changes Planned for FDAโ€™s Vaccine Advisory Committee โ€˜At This Timeโ€™: Spokesperson

There are no plans to remove any members of the panel that advises the FDA on vaccines, a spokesperson said on June 20.

Trump Says Trade Deals Expected With India and Pakistan

President Trump expects US will sign trade deals with India and Pakistan, signaling growing momentum in push to reshape global trade through tariff diplomacy.

Trump Says US Intelligence Communityโ€™s Assessment of Iranโ€™s Nuclear Program โ€˜Was Wrongโ€™

President Trump said his director of national intelligenceโ€™s assessment in March that Iran had yet to decide on building a nuclear weapon was wrong.

NIH Ends Gain-of-Function Research, Implementing Trumpโ€™s Executive Order

The NIH announced the end of gain-of-function research. The instituteโ€™s update said the move is in compliance with President Trumpโ€™s EO on the topic.ย 
spot_img

Related Articles